• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结膜黑色素瘤:一种独特类型黑色素瘤的遗传和表观遗传见解。

Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma.

机构信息

Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.

Medical Oncology, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

出版信息

Int J Mol Sci. 2019 Oct 31;20(21):5447. doi: 10.3390/ijms20215447.

DOI:10.3390/ijms20215447
PMID:31683701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6862213/
Abstract

Conjunctival melanoma (CjM) is a rare, primary cancer of the ocular region. Genetic and epigenetic characteristics of conjunctival melanoma have not been completely elucidated yet. Conjunctival melanoma presents similarities with cutaneous melanoma, with substantial differences in the biological behavior. We reviewed the genetic and epigenetic insights of CjM involved in invasion and metastatic spread. CjM is commonly characterized by mutations of v-raf murine sarcoma viral oncogene homolog B1 (), neurofibromin 1 () and telomerase reverse transcriptase (), high expression of mammalian target of rapamycin (mTOR) and heat shock protein 90 (HSP90), frequent phosphatase and tensin homolog (PTEN) loss and upregulation of specific miRNAs. These features should identify CjM as a distinct subset of melanoma with its own profile, which is more similar to cutaneous melanoma than mucosal melanoma and remarkably different from uveal melanoma.

摘要

结膜黑色素瘤(CjM)是一种罕见的眼部原发性癌症。结膜黑色素瘤的遗传和表观遗传特征尚未完全阐明。结膜黑色素瘤与皮肤黑色素瘤具有相似之处,但在生物学行为上存在显著差异。我们综述了参与浸润和转移扩散的 CjM 的遗传和表观遗传特征。CjM 通常表现为 v-raf 鼠肉瘤病毒致癌基因同源物 B1 ()、神经纤维瘤 1 () 和端粒酶逆转录酶 () 的突变,哺乳动物雷帕霉素靶蛋白(mTOR)和热休克蛋白 90 (HSP90) 的高表达,磷酸酶和张力蛋白同源物(PTEN)的频繁丢失以及特定 miRNAs 的上调。这些特征应将 CjM 鉴定为具有自身特征的黑色素瘤的一个独特亚群,与皮肤黑色素瘤更相似,与黏膜黑色素瘤显著不同,与葡萄膜黑色素瘤差异很大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef51/6862213/dbe620c59ea2/ijms-20-05447-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef51/6862213/8f97327fecee/ijms-20-05447-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef51/6862213/f55bb58fa641/ijms-20-05447-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef51/6862213/01432a30c11a/ijms-20-05447-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef51/6862213/dbe620c59ea2/ijms-20-05447-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef51/6862213/8f97327fecee/ijms-20-05447-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef51/6862213/f55bb58fa641/ijms-20-05447-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef51/6862213/01432a30c11a/ijms-20-05447-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef51/6862213/dbe620c59ea2/ijms-20-05447-g004.jpg

相似文献

1
Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma.结膜黑色素瘤:一种独特类型黑色素瘤的遗传和表观遗传见解。
Int J Mol Sci. 2019 Oct 31;20(21):5447. doi: 10.3390/ijms20215447.
2
Structural Protein Analysis of Driver Gene Mutations in Conjunctival Melanoma.结膜黑色素瘤驱动基因突变的结构蛋白分析。
Genes (Basel). 2021 Oct 15;12(10):1625. doi: 10.3390/genes12101625.
3
Genomic and transcriptomic landscape of conjunctival melanoma.结膜黑色素瘤的基因组和转录组图谱。
PLoS Genet. 2020 Dec 31;16(12):e1009201. doi: 10.1371/journal.pgen.1009201. eCollection 2020 Dec.
4
Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.丹麦的结膜恶性黑色素瘤:流行病学、治疗与预后,特别强调肿瘤发生和基因概况
Acta Ophthalmol. 2016 May;94 Thesis 1:1-27. doi: 10.1111/aos.13100.
5
NF1 mutations in conjunctival melanoma.结膜黑色素瘤中的 NF1 突变。
Br J Cancer. 2018 May;118(9):1243-1247. doi: 10.1038/s41416-018-0046-5. Epub 2018 Mar 21.
6
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.结膜黑色素瘤与皮肤和黏膜黑色素瘤具有相似的 BRAF 和 NRAS 突变及拷贝数改变。
Clin Cancer Res. 2013 Jun 15;19(12):3143-52. doi: 10.1158/1078-0432.CCR-13-0163. Epub 2013 Apr 30.
7
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours.TERT 启动子突变可区分眼黑色素瘤中的结膜肿瘤和葡萄膜肿瘤。
Br J Cancer. 2013 Jul 23;109(2):497-501. doi: 10.1038/bjc.2013.312. Epub 2013 Jun 25.
8
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.原发性皮肤黑色素瘤中BRAF、NRAS和PTEN基因突变的检测
J Invest Dermatol. 2006 Jan;126(1):154-60. doi: 10.1038/sj.jid.5700026.
9
Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.葡萄膜和结膜黑色素瘤以及良性和癌前结膜黑素细胞病变中TERT启动子突变的患病率及其影响
Invest Ophthalmol Vis Sci. 2014 Aug 26;55(9):6024-30. doi: 10.1167/iovs.14-14901.
10
Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways Inhibition.结膜黑色素瘤的靶向治疗:MAPK 和 PI3K/mTOR 通路抑制。
Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2764-2772. doi: 10.1167/iovs.18-26508.

引用本文的文献

1
Conjunctival melanoma: comprehensive insights into clinical features, genetic alterations, and modern treatment approaches.结膜黑色素瘤:对临床特征、基因改变及现代治疗方法的全面见解
Pathol Oncol Res. 2025 Aug 4;31:1612085. doi: 10.3389/pore.2025.1612085. eCollection 2025.
2
Subepithelial Lesions of the Ocular Surface: A Review.眼表上皮下病变:综述
Curr Ophthalmol Rep. 2025;13(1):8. doi: 10.1007/s40135-025-00335-8. Epub 2025 Jun 21.
3
Role of miRNA in adult ocular tumorigenesis.微小RNA在成人眼部肿瘤发生中的作用。

本文引用的文献

1
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.多个原发性黑色素瘤患者的种系和体细胞突变:下一代测序研究。
BMC Cancer. 2019 Aug 5;19(1):772. doi: 10.1186/s12885-019-5984-7.
2
Aberrant MicroRNA Expression and Its Implications for Uveal Melanoma Metastasis.异常微小RNA表达及其对葡萄膜黑色素瘤转移的影响。
Cancers (Basel). 2019 Jun 12;11(6):815. doi: 10.3390/cancers11060815.
3
Pembrolizumab as first-line treatment for metastatic uveal melanoma.派姆单抗作为一线治疗转移性葡萄膜黑色素瘤的药物。
Front Mol Biosci. 2025 May 8;12:1459761. doi: 10.3389/fmolb.2025.1459761. eCollection 2025.
4
Current findings of genetic alterations and associated targeted therapies of conjunctival melanocytic neoplasms.结膜黑素细胞肿瘤的基因改变及相关靶向治疗的当前研究结果
Taiwan J Ophthalmol. 2025 Mar 6;15(1):26-33. doi: 10.4103/tjo.TJO-D-24-00109. eCollection 2025 Jan-Mar.
5
Immune check point inhibitors for ocular adnexal and periocular tumors.用于眼附属器和眼周肿瘤的免疫检查点抑制剂。
Taiwan J Ophthalmol. 2025 Mar 6;15(1):14-25. doi: 10.4103/tjo.TJO-D-24-00130. eCollection 2025 Jan-Mar.
6
Malignant melanoma of the conjunctiva metastasizing to the submandibular gland: a case report and review of the literature.结膜恶性黑色素瘤转移至颌下腺:一例报告并文献复习
BMC Ophthalmol. 2025 Mar 13;25(1):130. doi: 10.1186/s12886-025-03949-5.
7
Immune Checkpoint Inhibitors in the Treatment of Ocular Surface Cancers: A Review.免疫检查点抑制剂在眼表癌治疗中的应用综述
Semin Ophthalmol. 2025 Feb 9:1-11. doi: 10.1080/08820538.2025.2458658.
8
Epigenetics of Conjunctival Melanoma: Current Knowledge and Future Directions.结膜黑色素瘤的表观遗传学:当前认知与未来方向。
Cancers (Basel). 2024 Oct 31;16(21):3687. doi: 10.3390/cancers16213687.
9
A Case of Conjunctival Melanoma Presenting as a Squamous Cell Carcinoma.一例表现为鳞状细胞癌的结膜黑色素瘤病例。
Case Rep Ophthalmol. 2024 Oct 25;15(1):742-750. doi: 10.1159/000541860. eCollection 2024 Jan-Dec.
10
Genetic Aspects of Conjunctival Melanoma: A Review.结膜黑色素瘤的遗传学研究进展:综述
Genes (Basel). 2023 Aug 23;14(9):1668. doi: 10.3390/genes14091668.
Cancer Immunol Immunother. 2019 Jul;68(7):1179-1185. doi: 10.1007/s00262-019-02352-6. Epub 2019 Jun 7.
4
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma.达拉非尼和曲美替尼用于BRAF突变型转移性结膜黑色素瘤的治疗
Front Oncol. 2019 Apr 5;9:232. doi: 10.3389/fonc.2019.00232. eCollection 2019.
5
Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome.结膜黑色素瘤的拷贝数改变与突变状态、肿瘤特征和临床结果的相关性。
Pigment Cell Melanoma Res. 2019 Jul;32(4):564-575. doi: 10.1111/pcmr.12767. Epub 2019 Feb 19.
6
Regulation of Tumor Suppressor Gene CDKN2A and Encoded p16-INK4a Protein by Covalent Modifications.肿瘤抑制基因CDKN2A及其编码的p16-INK4a蛋白的共价修饰调控
Biochemistry (Mosc). 2018 Nov;83(11):1289-1298. doi: 10.1134/S0006297918110019.
7
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma.热休克蛋白90(HSP90)抑制剂STA-9090(ganetespib)用于转移性葡萄膜黑色素瘤的II期试验结果。
Melanoma Res. 2018 Dec;28(6):605-610. doi: 10.1097/CMR.0000000000000509.
8
Upregulation of BCL2 19 kD Protein-Interacting Protein 3 (BNIP3) is Predictive of Unfavorable Prognosis in Uveal Melanoma.BCL2 19 kD 蛋白相互作用蛋白 3(BNIP3)的上调可预测葡萄膜黑色素瘤的不良预后。
Med Sci Monit. 2018 Jul 8;24:4711-4717. doi: 10.12659/MSM.907679.
9
Mechanistic considerations on the wavelength-dependent variations of UVR genotoxicity and mutagenesis in skin: the discrimination of UVA-signature from UV-signature mutation.关于 UVR 皮肤遗传毒性和致突变性的波长依赖性变化的机制考虑:UVA 特征与 UV 特征突变的区分。
Photochem Photobiol Sci. 2018 Dec 5;17(12):1861-1871. doi: 10.1039/c7pp00360a.
10
Conjunctival Melanoma - Epidemiological Trends and Features.结膜黑色素瘤——流行病学趋势与特征
Pathol Oncol Res. 2018 Oct;24(4):787-796. doi: 10.1007/s12253-018-0419-3. Epub 2018 May 25.